Proton Beam Therapy and Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma

J Thorac Oncol. 2019 Sep;14(9):e185-e187. doi: 10.1016/j.jtho.2019.05.013. Epub 2019 Jun 22.

Authors

Michael G McCusker¹, Katherine A Scilla¹, Charles B Simone 2nd², Ashutosh Sachdeva¹, Kenneth D Miller¹, Allen P Burke¹, Christian Rolfo³

Affiliations

¹ University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, Maryland.
² New York Proton Center, New York, New York.
³ University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, Maryland. Electronic address: Christian.rolfo@umm.edu.

PMID: 31235402
DOI: 10.1016/j.jtho.2019.05.013

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal / pharmacology
Antibodies, Monoclonal / therapeutic use*
Female
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Mesothelioma / drug therapy*
Mesothelioma / pathology
Mesothelioma, Malignant
Proton Therapy / methods*

Substances

Antibodies, Monoclonal